We appreciate the opportunity to address the comments by Yangfan Cheng and colleagues, and Sebastian Walsh and colleagues regarding our Article on long-term gantenerumab treatment in dominantly ...

We read with great interest the Article by Randall J Bateman and colleagues investigating long-term gantenerumab treatment in dominantly inherited Alzheimer's disease.1 This important work provides ...

California is on the cusp of a demographic shift, with the number of people 65 and older skyrocketing by 59% over the next 15 ...

The Alzheimer's Association of Greater Kentucky and Southern Indiana held the kickoff party on Wednesday for its Walk to End ...

The Broward Sheriff’s Office Missing Persons unit asked for the public’s help Wednesday in locating a 76-year-old man who ...

Newly published research claims those taking GLP-1 jabs are at a 37 percent lower risk of dementia than those on the anti-diabetic medication.

Single-cell genomics has unlocked new frontiers in understanding cell types in the brain and targeting them with therapies.

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

A free database of biomarker information on neurodegenerative diseases was released with backing from Bill Gates, Johnson & ...

Living with Alzheimer’s disease can be both challenging and frightening. However, stories of resilience and hope can inspire ...

Each year in the U.S., approximately 2.5 million people suffer traumatic brain injuries (TBIs). About 50,000 of these injuries will result in death, and more than 80,000 will lead to permanent ...

Your body provides many signs when it needs rest, including dark circles, muscle aches, and skin blemishes. Here’s how to ...